InvestorsHub Logo
Followers 16
Posts 395
Boards Moderated 0
Alias Born 06/07/2009

Re: None

Sunday, 10/03/2010 9:09:17 PM

Sunday, October 03, 2010 9:09:17 PM

Post# of 346543
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.

Alternative treatment strategies remain critically needed for this indication.
http://www.ncbi.nlm.nih.gov/pubmed/20853132
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News